Literature DB >> 8725949

Analysis of cell-adhesion molecule interactions using surface plasmon resonance.

P A van der Merwe1, A N Barclay.   

Abstract

The molecular interactions that mediate cell adhesion are often very weak, making them difficult to study. However, real-time optical biosensors based on surface plasmon resonance (SPR) are greatly facilitating the biochemical analysis of these interactions. Analysis of the T cell surface molecule CD2 has shown that adhesion molecules can interact with very low affinities (Kd approximately 100 microM) and dissociate with half lives of approximately 0.2 seconds or less. SPR has been combined with site-directed mutagenesis to delineate the interacting surfaces of CD2 and its ligand, CD48, quantify the contribution of individual residues to the binding energy, and determine the binding orientation of these surfaces in the CD2-CD48 complex. Furthermore, SPR has been combined with in situ modification of carbohydrates on purified glycoproteins to analyze the binding specificity of lectins such as CD22. Researchers have discovered the potential pitfalls of SPR, which can lead to inaccurate affinity and kinetic measurements.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8725949     DOI: 10.1016/s0952-7915(96)80065-3

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  24 in total

1.  A direct comparison of selectin-mediated transient, adhesive events using high temporal resolution.

Authors:  M J Smith; E L Berg; M B Lawrence
Journal:  Biophys J       Date:  1999-12       Impact factor: 4.033

2.  Calcium-dependent properties of CIB binding to the integrin alphaIIb cytoplasmic domain and translocation to the platelet cytoskeleton.

Authors:  D D Shock; U P Naik; J E Brittain; S K Alahari; J Sondek; L V Parise
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

3.  Study of the interaction of the medium chain mu 2 subunit of the clathrin-associated adapter protein complex 2 with cytotoxic T-lymphocyte antigen 4 and CD28.

Authors:  E R Follows; J C McPheat; C Minshull; N C Moore; R A Pauptit; S Rowsell; C L Stacey; J J Stanway; I W Taylor; W M Abbott
Journal:  Biochem J       Date:  2001-10-15       Impact factor: 3.857

4.  Combined affinity and rate constant distributions of ligand populations from experimental surface binding kinetics and equilibria.

Authors:  Juraj Svitel; Andrea Balbo; Roy A Mariuzza; Noreen R Gonzales; Peter Schuck
Journal:  Biophys J       Date:  2003-06       Impact factor: 4.033

5.  Human herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor.

Authors:  Mildred Foster-Cuevas; Gavin J Wright; Michael J Puklavec; Marion H Brown; A Neil Barclay
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

6.  Multivalent recombinant proteins for probing functions of leucocyte surface proteins such as the CD200 receptor.

Authors:  Despina Voulgaraki; Rita Mitnacht-Kraus; Michelle Letarte; Mildred Foster-Cuevas; Marion H Brown; A Neil Barclay
Journal:  Immunology       Date:  2005-07       Impact factor: 7.397

7.  Large-scale screening for novel low-affinity extracellular protein interactions.

Authors:  K Mark Bushell; Christian Söllner; Benjamin Schuster-Boeckler; Alex Bateman; Gavin J Wright
Journal:  Genome Res       Date:  2008-02-22       Impact factor: 9.043

8.  Identification of leucocyte surface protein interactions by high-throughput screening with multivalent reagents.

Authors:  Lei Jiang; A Neil Barclay
Journal:  Immunology       Date:  2010-01       Impact factor: 7.397

9.  Extending the range of rate constants available from BIACORE: interpreting mass transport-influenced binding data.

Authors:  D G Myszka; X He; M Dembo; T A Morton; B Goldstein
Journal:  Biophys J       Date:  1998-08       Impact factor: 4.033

Review 10.  Signal initiation in biological systems: the properties and detection of transient extracellular protein interactions.

Authors:  Gavin J Wright
Journal:  Mol Biosyst       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.